Nath Bio-Genes (India) Share Price

167.32-0.90 (-0.53%)

Closed
As On: 23 Jun, 2026, 03:51 PM IST
As On: 23 Jun, 2026, 03:48 PM IST

Sector: Agriculture/Hor...
Industry: Seeds/Tissue Cultu...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	169.70
High	169.90
Low	166.01
Prev Close	168.21
Volume	22,217
VWAP(₹)	167.81

Share Price	Value
Today/Current/Last	167.32167.80
Previous Day	168.21168.60

Nath Bio-Genes Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Nath Bio-Genes Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	53.97	67.69	45.78	285.46	55.83
Total Income Growth (%)	-20.28	47.85	-83.96	411.31	49.47
Total Expenses	46.88	60.67	36.67	246.39	52.90
Total Expenses Growth (%)	-22.73	65.46	-85.12	365.81	78.33
EBIT	7.08	7.02	9.11	39.07	2.93
EBIT Growth (%)	0.90	-22.98	-76.67	1,231.79	-61.85
Profit after Tax (PAT)	-0.01	1.61	2.75	37.28	1.48
PAT Growth (%)	-100.55	-41.71	-92.61	2,417.29	-44.12
EBIT Margin (%)	13.13	10.37	19.91	13.69	5.26
Net Profit Margin (%)	-0.02	2.37	6.01	13.06	2.65
Basic EPS (₹)	-0.79	0.84	1.40	19.58	0.42

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	48.07	67.70	41.70	281.94	53.41
Total Income Growth (%)	-28.99	62.32	-85.21	427.86	43.00
Total Expenses	38.85	55.42	33.56	242.24	47.52
Total Expenses Growth (%)	-29.90	65.13	-86.15	409.79	57.40
EBIT	9.22	12.28	8.15	39.69	5.89
EBIT Growth (%)	-24.91	50.78	-79.48	573.60	-17.72
Profit after Tax (PAT)	3.79	7.23	4.20	38.21	4.71
PAT Growth (%)	-47.61	72.15	-89.01	711.34	77.36
EBIT Margin (%)	19.19	18.14	19.53	14.08	11.03
Net Profit Margin (%)	7.88	10.68	10.07	13.55	8.82
Basic EPS (₹)	2.17	3.80	2.16	20.06	2.12

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	452.91	369.45	333.25	301.92	280.22
Total Revenue Growth (%)	22.59	10.86	10.38	7.74	102.64
Total Expenses	412.62	329.41	295.14	265.75	254.87
Total Expenses Growth (%)	25.26	11.61	11.06	4.27	102.30
Profit after Tax (PAT)	41.63	38.60	39.62	35.01	-67.39
PAT Growth (%)	7.85	-2.57	13.16	-	-673.70
Operating Profit Margin (%)	12.64	13.84	14.19	15.35	12.91
Net Profit Margin (%)	9.35	10.57	11.91	11.61	-24.20
Basic EPS (₹)	20.98	19.85	19.52	18.43	-35.55

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	439.41	367.04	333.28	301.85	280.22
Total Revenue Growth (%)	19.72	10.13	10.41	7.72	-9.38
Total Expenses	396.32	323.45	294.60	265.53	254.82
Total Expenses Growth (%)	22.53	9.79	10.95	4.20	0.93
Profit after Tax (PAT)	44.43	42.14	40.18	35.17	-67.34
PAT Growth (%)	5.42	4.89	14.25	-	-220.98
Operating Profit Margin (%)	13.06	14.69	14.36	15.41	12.93
Net Profit Margin (%)	10.29	11.63	12.07	11.67	-24.19
Basic EPS (₹)	23.42	21.72	19.81	18.51	-36.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 22.59% outperformed its 3 year CAGR of 14.32%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.59% of its operating revenues towards interest expenses and 8.04% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,097.42	1,026.21	880.23	792.80	739.49
Total Assets Growth (%)	6.94	16.58	11.03	7.21	367.19
Total Liabilities	416.96	381.82	270.31	219.64	197.57
Total Liabilities Growth (%)	9.20	41.25	23.07	11.17	95.98
Total Equity	680.46	644.39	609.92	573.15	541.92
Total Equity Growth (%)	5.60	5.65	6.41	5.76	842.90
Current Ratio (x)	1.97	1.89	2.18	2.41	2.41
Total Debt to Equity (x)	0.20	0.19	0.18	0.18	0.17
Contingent Liabilities	0.00	92.62	99.56	79.10	68.24

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,082.90	1,016.87	877.08	792.97	741.91
Total Assets Growth (%)	6.49	15.94	10.61	6.88	-6.03
Total Liabilities	393.53	368.20	266.42	219.62	199.94
Total Liabilities Growth (%)	6.88	38.20	21.31	9.84	13.45
Total Equity	689.37	648.67	610.66	573.35	541.97
Total Equity Growth (%)	6.27	6.22	6.51	5.79	-11.63
Current Ratio (x)	1.97	1.87	2.18	2.41	2.39
Total Debt to Equity (x)	0.18	0.17	0.18	0.18	0.17
Contingent Liabilities	0.00	132.35	99.56	79.10	68.30

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-12.57	17.58	74.59	38.37	17.05
Net Cash used in Investing Activities	3.46	-3.96	-27.40	-2.88	-19.85
Net Cash flow from Financing Activities	-3.81	-2.13	-7.78	-1.67	-22.23
Net Cash Flow	-12.93	11.49	39.41	33.81	-25.04
Closing Cash & Cash Equivalent	75.97	88.90	77.41	38.00	4.18
Closing Cash & Cash Equivalent Growth (%)	-14.54	14.84	103.74	808.85	68.74
Total Debt/ CFO (x)	-11.02	6.97	1.48	2.74	5.45

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-13.91	26.80	74.72	38.37	17.05
Net Cash used in Investing Activities	3.46	-4.05	-27.40	-2.88	-19.87
Net Cash flow from Financing Activities	-6.51	-10.62	-9.81	-1.67	-22.23
Net Cash Flow	-16.96	12.13	37.52	33.82	-25.05
Closing Cash & Cash Equivalent	70.67	87.63	75.50	37.98	4.17
Closing Cash & Cash Equivalent Growth (%)	-19.36	16.07	98.77	811.34	-85.73
Total Debt/ CFO (x)	-8.75	4.15	1.45	2.74	5.45

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	6.11	5.99	6.49	6.10	-12.43
Return on Capital Employed (%)	8.00	7.64	7.64	8.03	6.59
Return on Assets (%)	3.79	3.76	4.50	4.41	-9.11
Interest Coverage Ratio (x)	3.77	5.18	5.54	4.87	3.68
Asset Turnover Ratio (x)	0.42	0.38	0.40	0.39	-
Price to Earnings (x)	5.83	7.18	8.34	7.69	-6.02
Price to Book (x)	0.36	0.43	0.54	0.47	0.75
EV/EBITDA (x)	5.06	5.72	7.19	6.83	12.66
EBITDA Margin (%)	13.53	14.89	15.17	16.35	14.02

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	6.44	6.49	6.57	6.13	-12.42
Return on Capital Employed (%)	8.11	8.14	7.74	8.05	6.60
Return on Assets (%)	4.10	4.14	4.58	4.43	-9.07
Interest Coverage Ratio (x)	4.53	5.91	5.61	4.89	3.68
Asset Turnover Ratio (x)	0.41	0.38	0.40	0.39	0.36
Price to Earnings (x)	5.46	6.58	8.22	7.66	-6.02
Price to Book (x)	0.35	0.43	0.54	0.47	0.75
EV/EBITDA (x)	4.87	5.27	7.11	3.34	12.64
EBITDA Margin (%)	13.98	15.73	15.34	16.41	14.04

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Nath Bio-Genes	7.64	0.47	6.11	8.00	3.79	14.32	12.64	9.35	20.98	1.97	0.20	-11.02
Kaveri Seed Co.	16.18	2.73	16.83	17.00	10.72	8.08	21.94	21.21	56.94	2.14	0.00	0.00
Adv Enzyme Tech	24.84	2.49	10.33	12.92	9.17	11.18	30.01	23.27	15.08	9.78	0.01	0.13
Bombay Super Hybrid	36.00	7.32	20.34	26.07	10.49	14.54	10.12	7.74	2.54	2.02	0.83	-6.85
Indo Us Bio-Tech	13.70	1.94	14.18	17.27	9.85	21.16	14.63	11.88	6.54	3.05	0.40	-2.30
Add More

Annual Ratios (%)

Choose from Peers

Shreeoswal Seeds
Agri-Tech (India)

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Nath Bio-Genes Stock Performance	-0.53	4.07	-2.00	13.69	-13.17	3.19	-60.52
Kaveri Seed Co. Stock Performance	-1.44	-0.34	-1.53	14.57	-33.33	81.32	19.82
Adv Enzyme Tech Stock Performance	-0.15	2.51	25.79	19.64	29.48	36.10	-21.99
Bombay Super Hybrid Stock Performance	-1.13	-5.56	-9.39	-0.78	-34.88	-70.07	375.01
Indo Us Bio-Tech Stock Performance	-3.25	-15.15	-16.11	-40.51	-39.69	0.00	0.00
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	86,64,902	45.60 %	0.00
Pledge	11,94,000	13.78 %	0.00
FII	43,206	0.22 %	-0.09
DII	2,200	0.01 %	0.00
MF	2,200	0.01 %	0.00
Others	1,02,93,692	54.17 %	0.09

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	45.60	45.60	45.60	45.60
Pledge	13.78	13.78	13.78	13.78
FII	0.22	0.31	0.32	0.41
DII	0.01	0.01	0.76	2.25
Mutual Funds	0.01	0.01	0.76	2.25
Others	54.17	54.08	53.32	51.74

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Final
20%
May 04, 2026
Board Meeting
Audited Results & Final Dividend
Apr 27, 2026
Board Meeting
Quarterly Results
Jan 27, 2026

Board Meetings

Announced on	Meeting on
Apr 27, 2026	May 04, 2026
Audited Results & Final Dividend
Jan 27, 2026	Jan 31, 2026
Quarterly Results
Nov 06, 2025	Nov 13, 2025
Quarterly Results
Jul 04, 2025	Jul 11, 2025
Quarterly Results
Apr 21, 2025	Apr 29, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Apr 29, 2025 Aug 14, 2025 20%
May 08, 2024 Aug 09, 2024 20%
Apr 24, 2023 Jul 04, 2023 20%
May 30, 2022 Jun 23, 2022 20%
May 04, 2026 - 20%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
Apr 29, 2025	Aug 14, 2025	20%
May 08, 2024	Aug 09, 2024	20%
Apr 24, 2023	Jul 04, 2023	20%
May 30, 2022	Jun 23, 2022	20%
May 04, 2026	-	20%

AGM/EGM Meetings

Announced on	Meeting on
Apr 29, 2025	Aug 22, 2025
-
May 08, 2024	Aug 17, 2024
Book closure from Aug 13, 2024 to Aug 17, 2024
Jan 19, 2024	Mar 12, 2024
-
May 23, 2023	Jul 11, 2023
Rs.2.0000 per share(20%)Final Dividend & A.G.M. (Revised)
Apr 24, 2023	Jun 30, 2023
Book closure from Jun 25, 2023 to Jun 30, 2023

About Nath Bio-Genes

Nath Bio-Genes (India) Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 317.97 Crore) operating in Agriculture/Horticulture/Livestock sector.

Nath Bio-Genes (India) Ltd. key Products/Revenue Segments include Agricultural Products and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 53.97 Crore, down 20.28 % from last quarter Total Income of Rs 67.69 Crore and down 3.33 % from last year same quarter Total Income of Rs 55.83 Crore. Company has reported net profit after tax of Rs -.01 Crore in latest quarter.

The company’s top management includes Mr.Satish Kagliwal, Mr.Akash Kagliwal, Ms.Ashu Jain, Mr.Hitesh Purohit, Mrs.Jeevanlata Kagliwal, Mr.Madhukar Deshpande, Mr.Vadla Nagabhushanam, Mr.Amol Gupta, Mr.Dhiraj Rathi. Company has Ashok R Majethia & Co. as its auditors. As on 31-03-2026, the company has a total of 1.90 Crore shares outstanding.

Nath Bio-Genes Share Price Today is Rs. 167.32. On previous day, the Nath Bio-Genes Share Price (NSE) closed at Rs. 160.78, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 45.6% of the stake in Nath Bio-Genes shares, out of which 13.78% was pledged. On the same date, foreign institutional investors' (FII) holdings of Nath Bio-Genes stocks was 0.22% as compared to 0.31% in Dec 2025 with decrease of 0.09%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.01% as compared to 0.01% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Nath Bio-Genes shares 0.01% was held by mutual funds. The rest including public held is 54.17%. Nath Bio-Genes stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Nath Bio-Genes Dividend: Ever since 1993, Nath Bio-Genes dividends has been paid out around 6 times. As on 23 Jun, 2026, 03:51 PM IST, The overall dividend yield for Nath Bio-Genes stands at 1.19%. The last dividend paid was on August 14, 2025 (Rs. 2.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 21.91.

Nath Bio-Genes Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 53.97 Cr. of sales and 20.28% of quarterly net loss, there have been multiple ups and downs in the Nath Bio-Genes stock prices in the past few weeks. For example, Nath Bio-Genes stock price on 15th of June 2026 was around Rs. 169.02. Nath Bio-Genes share price now stands at an average of Rs. 167.32. Judging by last week's performance, stock is in down trend.

Nath Bio-Genes has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Nath Bio-Genes share.

Historical Prices and Performance:
Nath Bio-Genes ,incorporated in 1993 is a Small Cap company (with a market cap of Rs. 319.67) operating in Agriculture/Horticulture/Livestock sector.
The Return of Equity (ROE) in last five financial years given by Nath Bio-Genes stock was 6.11%, 5.99%, 6.49%, 6.1% and -12.43% respectively.
The Nath Bio-Genes share gave a 3 year return of -9.9% as compared to Nifty 50 which gave a return of 28.4%.
Nath Bio-Genes announced 20.0% final dividend on August 14, 2025.

Key Metrics:
PE Ratio of Nath Bio-Genes is 7.68
Prices/Sales Ratio of Nath Bio-Genes is 0.55
Price/Book Ratio of Nath Bio-Genes is 0.47

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Nath Bio-Genes ,major competitors and peers include Kaveri Seed Co., Adv Enzyme Tech, Bombay Super Hybrid and Indo Us Bio-Tech. As of Dec 2025, the dividend yield of Nath Bio-Genes stands at 1.19% while Kaveri Seed Co., Adv Enzyme Tech, Bombay Super Hybrid and Indo Us Bio-Tech stand at 0.53%, 1.39%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 7.68 and 0.47 respectively.

Leadership of Nath Bio-Genes :
Dhiraj Rathi is Co. Secretary & Compl. Officer
Amol Gupta is Chief Financial Officer
Satish Kagliwal is Managing Director
Madhukar Deshpande is Director
Ashu Jain is Director
Jeevanlata Kagliwal is Director
Vadla Nagabhushanam is Director
Hitesh Purohit is Director
Akash Kagliwal is Director

Industry

Seeds/Tissue Culture/Bio Technology

Key Indices Listed On

-

Address

Nath House,Nath Road,Aurangabad, Maharashtra - 431005

Contact

investor@nathbiogenes.com

http://www.nathbiogenes.com

PE Ratio(x)	7.64
EPS - TTM(₹)	21.91
MCap(₹ Cr.)	317.97
MCap Rank	11
PB Ratio(x)	0.47
Div Yield(%)	1.20
Face Value(₹)	10.00
52W High(₹)	238.69
52W Low(₹)	126.15
MCap/Sales	0.55
Beta(1 Month)	1.02
BV/Share(₹)	358.06

PE Ratio(x)	7.66
EPS - TTM(₹)	21.91
MCap(₹ Cr.)	318.89
MCap Rank	13
PB Ratio(x)	0.47
Div Yield(%)	1.19
Face Value(₹)	10.00
52W High(₹)	238.00
52W Low(₹)	126.75
MCap/Sales	0.55
Beta(1 Month)	0.89
BV/Share(₹)	358.06

1 Day	-0.53%
1 Month	-3.19%
3 Months	24.66%
1 Year	-15.58%
3 Years	-9.58%
5 Years	-60.03%

1 Day	-0.47%
1 Month	-2.27%
3 Months	24.48%
1 Year	-15.06%
3 Years	-9.1%
5 Years	-59.85%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Nath Bio-Genes (India) Share Price

Key Metrics

Nath Bio-Genes share price insights

Nath Bio-Genes Share Price Returns

Nath Bio-Genes Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Nath Bio-Genes Top Searches

Corporate Actions

About Nath Bio-Genes

Executive Leadership

Auditors

FAQs about Nath Bio-Genes share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News